Detalles de la búsqueda
1.
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Int J Clin Oncol
; 28(10): 1354-1368, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548831
2.
Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Int J Clin Oncol
; 28(10): 1369-1370, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684530
3.
Early goal-directed resuscitation of patients with septic shock: current evidence and future directions.
Crit Care
; 19: 286, 2015 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26316210
4.
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
J Clin Oncol
; 41(6): 1200-1212, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223558
5.
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
J Thorac Oncol
; 18(8): 1055-1069, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146754
6.
HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment.
Am J Pathol
; 176(6): 2776-84, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20382699
7.
Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches.
Cancer Discov
; 11(5): 1024-1039, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722796
8.
Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
Mol Cancer Res
; 15(9): 1127-1137, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28596419
Resultados
1 -
8
de 8
1
Próxima >
>>